Apple Watch 健身三圈今日完成了嗎？下星期四要去 Apple Store 拎特別版襟章
每天定時做運動減肥是都市人最大的願望，但生活上又會有很多阻礙？十年以來，Apple Watch 內建的「健身記錄」以簡單直接、個人化的三色圓圈來鼓勵和推動使用者每天達到站立、運動、活動的目標。Apple 為隆重慶祝這十週年的里程碑，選定 2025 年 4 月 24 日為「Global Close Your Rings Day」，同時以線上和線下活動來加強推廣 Apple Watch 推動用戶健身的用法。
據 Apple 與學術界和醫學界合作的研究指出，「健身記錄」圓圈的圓滿達成，與睡眠、心臟健康及心理健康等方面之間存在正面關係。與不常圓滿達成「健身記錄」圓圈的用户相比，時常圓滿達成圓圈的用户出現睡眠質素欠佳 (即夜間頻繁睡醒) 的機會低 48%；出現靜止心率升高的機會亦低 73%；壓力升高的機會亦低 57%。
在 Global Close Your Rings Day 當天完成 Apple Watch 三色圓圈的用戶，同時以 #CloseYourRings 分享，就可以在 Apple 健身 app 裡得到限量版特別獎章，以及適用於「訊息」app 的 10 款動態貼圖與一枚動態徽章的線上活動。
Apple 同日也有線下的實體活動，4 月 24 日起，在全球各地的 Apple Store 零售店索取特別徽章同款的實體別針，數量有限，送完即止。
Amazon 特價 US$359（約 HK$2,785，需要代運）｜原價 US$429
立即購買
Apple 官網 HK$3,399
立即購買
Apple Watch Ultra 2
Amazon 特價 US$739（約 HK$5,732，需要代運）｜原價 US$799
立即購買
Apple 官網 HK$6,399
立即購買
更多內容：
戴上 Apple Watch 盡展活力（Apple）
Apple Watch Ultra 2 評測｜Ultra 2 值得買嗎？老用戶談兩代差異、主要賣點的實用度
Apple Watch Ultra 極限評測：潛水實測 + 專業跑手分享
緊貼最新科技資訊、網購優惠，追隨 Yahoo Tech 各大社交平台！
🎉📱 Tech Facebook：https://www.facebook.com/yahootechhk
🎉📱 Tech Instagram：https://www.instagram.com/yahootechhk/
🎉📱 Tech WhatsApp 社群：https://chat.whatsapp.com/Dg3fiiyYf3yG2mgts4Mii8
🎉📱 Tech WhatsApp 頻道：https://whatsapp.com/channel/0029Va91dmR545urVCpQwq2D
🎉📱 Tech Telegram 頻道：https://t.me/yahootechhk
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Diagnostic Electrocardiograph/ECG Market worth US$15.18 billion by 2032 with 7.4% CAGR
DELRAY BEACH, Fla., June 13, 2025 /PRNewswire/ -- The global Diagnostic Electrocardiograph/ECG Market, valued at US$8.59 billion in 2024 stood at US$9.19 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2032, culminating in a forecasted valuation of US$15.18 billion by the end of the period. The growth in the ECG diagnostic market can be attributed to several critical factors. The rising prevalence of chronic conditions, particularly CVDs, is a significant driver. Additionally, there is a marked shift towards home healthcare solutions, propelled by advancements in wearable technology and the broader digital transformation within the healthcare sector. The burgeoning geriatric demographic, which is increasingly susceptible to cardiac disorders, further amplifies the demand for ECG diagnostics across various healthcare environments. Technological innovations, specifically the advent of portable ECG devices and AI-enhanced ECG interpretation, are enhancing diagnostic precision and improving patient accessibility. Moreover, government initiatives aimed at promoting cardiac health, coupled with a growing acceptance of point-of-care diagnostic methodologies, are anticipated to bolster market growth moving forward. Download PDF Brochure: Browse in-depth TOC on "Diagnostic Electrocardiograph/ECG Market" 150 - Tables60 - Figures250 - Pages By Product, the diagnostic ECG market is categorized into diagnostic ECG devices and diagnostic ECG software & services, with the diagnostic ECG devices segment commanding the largest market share. This predominance is attributable to the critical role these devices play in routine cardiac diagnostics, the swift identification of arrhythmias, and long-term cardiac monitoring. Standard resting ECGs serve as fundamental assessments in both primary care and specialized medical environments, while Holter monitors facilitate extensive and continuous cardiac surveillance over extended periods. The demand for these diagnostic tools is significantly influenced by the rising geriatric population, which correlates with an increase in CVD prevalence within this demographic. According to WHO, over 80% of CVD-related fatalities result from heart attacks and strokes, with one-third of these deaths occurring prematurely in individuals under 70 years of age; this statistic underscores the urgent need for effective cardiac monitoring solutions in the face of growing cardiovascular health challenges. By lead type, the diagnostic ECG market is categorized based on lead types into 12-lead, 5-lead, 3-lead, 6-lead, and single-lead ECG devices. Notably, 12-lead ECG systems dominate the market due to their superior diagnostic capabilities, allowing for precise measurement of cardiac electrical activity. Regarded as the gold standard for the advanced diagnosis of cardiac pathologies, including myocardial infarctions and arrhythmias, these systems are widely endorsed by clinical guidelines for use in hospitals and cardiology clinics. Their approval for emergency and critical care applications further cements their market leadership. Key manufacturers of 12-lead diagnostic ECG devices include Koninklijke Philips N.V. (Netherlands), ACS Diagnostics (US), OSI Systems, Inc. (US), and GE Healthcare (US). By type, the diagnostic ECG market is further segmented into portable, wearable, and implantable ECG devices. In 2024, the portable ECG devices segment accounted for the largest market share, driven by their convenience, mobility, and diverse applications in both clinical settings and home care. Unlike traditional ECG machines, which are typically bulkier and stationary, portable devices enable on-demand or continuous cardiac monitoring from virtually any location. A significant advantage of these devices is their ability to wirelessly record and transmit ECG data to healthcare providers, facilitating remote patient monitoring. This capability not only allows for timely interventions but also minimizes the need for frequent hospital visits, which is particularly beneficial for patients with chronic heart conditions. As a result, the emphasis on remote patient care and the demand for personalized healthcare solutions are the primary factors propelling the growth of portable ECG devices, solidifying their dominant position within the diagnostic ECG market. By end user, the diagnostic ECG market is segmented into hospitals, primary care centers, cardiac centers, ambulatory surgery centers, urgent care settings, and home care settings. The hospitals segment held the largest market share primarily due to the high volume of cardiovascular patient admissions and the presence of state-of-the-art diagnostic infrastructure. The integration of ECG systems with other cardiac diagnostic modalities enhances their utility in both inpatient and outpatient settings, especially within emergency and ICUs. The increasing rates of hospital admissions for cardiac conditions, combined with the emphasis on early detection and timely intervention, position hospitals as the predominant end users of ECG technologies; this trend is a key driver of overall market expansion in the diagnostic ECG market. By geography, the diagnostic ECG market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The North American market has successfully secured a substantial share, driven by several key factors. One major contributor is the growth in the geriatric population, which is leading to an increased demand for healthcare services and diagnostic tools. Alongside this demographic shift, there has been a notable rise in the prevalence of chronic diseases, such as CVDs and diabetes, that require regular monitoring and management through advanced diagnostic ECG solutions. Additionally, the enhancement of healthcare infrastructure in the region plays a crucial role in facilitating better access to these diagnostic services. Hospitals & clinics are increasingly equipped with state-of-the-art technology and resources, enabling healthcare providers to offer timely and effective care. Furthermore, supportive government initiatives aimed at improving healthcare accessibility also have a positive impact on the market. Policies designed to reduce barriers to healthcare services and promote innovative diagnostic technologies are helping to ensure that patients can receive necessary care without significant obstacles. The strategic expansion of key players in the North American market, which includes both established companies and emerging startups, is anticipated to further bolster market growth. The active presence of these industry leaders not only enhances competition but also drives innovation in product development, ultimately benefiting patients and healthcare providers alike. Overall, these factors collectively signify a robust growth trajectory for the ECG diagnostic solutions market in North America. Request Sample Pages : As of 2024, diagnostic ECG market was dominated by GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Baxter (US), FUKUDA DENSHI (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), NIHON KOHDEN CORPORATION (Japan), OSI Systems, Inc. (US), Bittium (Finland), iRhythm Technologies, Inc. (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), Midmark Corporation (US), BPL Medical Technologies (India), SCHILLER (Switzerland), ACS Diagnostics (US), Allengers (India), and Bionet Co., Ltd. (South Korea), among others. GE Healthcare (US): GE Healthcare is a well-established entity in the diagnostic ECG sector, boasting over 125 years of industry experience and a formidable reputation within the global healthcare landscape. The company effectively utilizes its extensive global footprint in medical technology, diagnostics, and digital solutions, catering to a diverse clientele across 160 countries while adhering to sustainable operational practices. Central to GE Healthcare's strategy is a robust emphasis on R&D to optimize existing offerings and innovate new products and services. This commitment allows the company to stay responsive to evolving customer demands and to capitalize on emerging market opportunities. In a notable move for 2024, GE Healthcare invested approximately USD 969 million to enhance manufacturing capabilities and local R&D initiatives in India over the next five years. The company's growth strategy encompasses a range of collaborations, agreements, expansions, and acquisitions to strengthen its operational reach and market presence. These strategic endeavors not only expand the product portfolio but also fortify the company's competitive standing in the market. In a recent development, GE Healthcare partnered with the Mayo Clinic in September 2023 to leverage advanced technologies and improve the precision of diagnostics and treatment processes for healthcare providers. Koninklijke Philips N.V. (Netherlands) Koninklijke Philips N.V. (Royal Philips) serves as the parent organization of the Philips Group, strategically operating across four core domains: Personal Health, Diagnosis & Treatment, Connected Care, and Others. Within the Connected Care segment, Philips provides advanced diagnostic solutions, including cardiographs, Holter monitoring systems, and stress-testing ECGs. The company's growth strategy is heavily centered on forming strategic partnerships in high-potential markets and fostering collaborative efforts to drive innovation. A notable example of this approach is the 2023 partnership with NYU Langone Health to leverage innovative technologies and enhance patient care over an eight-year span. Additionally, in January 2025, Philips is set to present its latest innovations at Arab Health 2025. These advancements emphasize the integration of smart systems, automation, and cloud-based informatics into healthcare delivery, targeting reductions in clinician workload and improvements in operational workflows, ultimately leading to enhanced patient outcomes. Key subsidiaries within the Philips ecosystem include Philips Oral Healthcare, LLC (US), Philips GmbH (Germany), Philips Ultrasound, Inc. (US), and Philips Consumer Lifestyle B.V. (Netherlands). The company maintains a comprehensive operational footprint across North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Shenzhen Mindray Bio-Medical Electronics Co. (China) Shenzhen Mindray Bio-Medical Electronics is a prominent entity in the diagnostic ECG segment, distinguished by its diverse operational structure across three primary business verticals: Patient Monitoring and Life Support, In-vitro Diagnostics, and Medical Imaging Systems. Within the Patient Monitoring & Life Support sector, the company delineates its offerings into Patient Monitoring Systems, ECG devices, and ancillary products. Mindray dedicates more than 10% of its revenue to R&D, which underpins its commitment to innovation and sustains a formidable portfolio of over 3,000 patents. This investment not only fuels technological advancement but also strengthens its competitive edge. The company has also established strategic partnerships to enhance its market penetration and product offerings. Notably, its collaboration with Amazon Business facilitates improved access to medical equipment for healthcare systems, hospitals, and practitioners, streamlining procurement and distribution channels in a rapidly evolving healthcare landscape. For more information, Inquire Now! Related Reports: Cardiac Monitoring & Cardiac Rhythm Management Devices Market Patient Monitoring Devices Market Brain Monitoring Market Patient Temperature Monitoring Market MRI Systems Market Get access to the latest updates on Diagnostic Electrocardiograph/ECG Companies and Diagnostic Electrocardiograph/ECG Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content to download multimedia: SOURCE MarketsandMarkets
Yahoo
8 hours ago
- Yahoo
What If Something Happens To The Person In Control Of An Irrevocable Trust? Suze Orman Weighs In
When a listener named Kim wrote to Suze Orman's "Women & Money" podcast, she shared a common concern: Her family was overwhelmed by estate planning. Kim explained that her parents were considering setting up both a revocable trust and an irrevocable trust. Their goal? To stay in control of their assets while they're healthy and to potentially shield those assets — like their home and savings — if they ever need to enter a nursing home. But Kim and her family were confused. Would this strategy actually protect their assets? And what happens if the person managing the trust — known as the trustee — can't do the job anymore? Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Many are rushing to Orman encouraged Kim and her family to slow down and consider the bigger picture: "People first, then money, then things." That's been her mantra for more than two decades. While an irrevocable trust can, in some cases, protect assets from being counted for Medicaid eligibility, Orman pointed out a major trade-off: "It no longer is part of your estate. It's now out of your hands. Somebody else is in control of it — you are not." That loss of control can create problems down the line, especially if the trustee dies or becomes incapacitated. "What happens if something happens to the person who has control over it? It can become very, very complicated," Orman said. Trending: Invest where it hurts — and help millions heal:. Kim's family was also hoping the irrevocable trust would help cover nursing home care. Orman warned against relying on Medicaid as a solution. In her view, the quality of care for Medicaid patients often isn't comparable to that of private-pay residents. She pointed out that some nursing homes are already closing due to a lack of funding, and future changes to Medicaid or Medicare could make the situation worse. "To put this money, your parents' money, in front of their care just so you could be OK and have the money, the house can be protected, is not something that I advise," she said. While she was critical of irrevocable trusts in this situation, Orman did support the idea of a revocable trust — a legal tool that allows the creators (usually the parents) to stay in full control of their assets. If they become incapacitated, a successor trustee can step in. When they pass away, the assets can go directly to heirs without going through parents were on the right track by also looking into a durable power of attorney and healthcare directive — documents Orman includes in what she calls the "must-have documents" for every estate plan. Irrevocable trusts may sound like a great way to protect assets, but they come with significant limitations and long-term consequences — especially if the trustee can no longer serve. For families like Kim's, Orman's advice is clear: prioritize flexibility and personal care over trying to preserve wealth at all costs. A revocable trust, paired with essential legal documents, can offer both control and peace of mind as loved ones age. Read Next: Can you guess how many retire with a $5,000,000 nest egg? . Inspired by Uber and Airbnb – Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets – Image: Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article What If Something Happens To The Person In Control Of An Irrevocable Trust? Suze Orman Weighs In originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 hours ago
- Yahoo
Protein Chips Industry Analysis (2025-2030) Featuring Strategic Profiles of 42 Market Players Including Abcam, Agilent and Roche Diagnostics
As precision medicine rises, protein chips play a pivotal role in diagnostics and drug discovery, with applications expanding in oncology, autoimmune disorders, and environmental testing. Regionally, the U.S. market was valued at $633.4 million in 2024, while China is anticipated to grow at a 6% CAGR to $552.8 million by 2030. Major players include Abcam, Agilent, and Roche Diagnostics. Protein Chips Market Dublin, June 13, 2025 (GLOBE NEWSWIRE) -- The "Protein Chips - Global Strategic Business Report" has been added to global market for Protein Chips was valued at US$2.4 Billion in 2024 and is projected to reach US$3.4 Billion by 2030, growing at a CAGR of 6.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Protein Chips market. The growth in the protein chips market is driven by several factors stemming from advancements in microarray technology, broader end-use applications, and increased demand for personalized medicine. Technologically, innovations in signal detection, miniaturization, and chip reproducibility are making protein chips more powerful and accessible. End-use growth is seen in pharmaceutical R&D, molecular diagnostics, and point-of-care testing, where fast and multiplexed protein analysis is critical. Consumers especially in wellness and genomics are also driving demand for individualized proteomic data, supporting use cases in preventive healthcare. Further, the expansion of proteomics infrastructure in Asia-Pacific and increased public-private research funding are contributing to the global scaling of protein chip manufacturing and adoption. These converging trends are establishing protein chips as a linchpin technology in modern biomedical research and diagnostics. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Abcam plc, Agilent Technologies Inc., Arrayit Corporation, Ayoxxa Biosystems GmbH, and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Key Insights: Market Growth: Understand the significant growth trajectory of the Analytical Microarrays segment, which is expected to reach US$1.5 Billion by 2030 with a CAGR of a 4.5%. The Functional Protein Microarrays segment is also set to grow at 8% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $633.4 Million in 2024, and China, forecasted to grow at an impressive 6.0% CAGR to reach $552.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Why You Should Buy This Report: Detailed Market Analysis: Access a thorough analysis of the Global Protein Chips Market, covering all major geographic regions and market segments. Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies. Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Protein Chips Market. Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions. Key Questions Answered: How is the Global Protein Chips Market expected to evolve by 2030? What are the main drivers and restraints affecting the market? Which market segments will grow the most over the forecast period? How will market shares for different regions and segments change by 2030? Who are the leading players in the market, and what are their prospects? Some of the 42 companies featured in this Protein Chips market report include: Abcam plc Agilent Technologies Inc. Arrayit Corporation Ayoxxa Biosystems GmbH Bio-Rad Laboratories Inc. CDI Laboratories Inc. Danaher Corporation Full Moon BioSystems Inc. Illumina Inc. Innopsys S.A. Luminex Corporation Microarrays Inc. OriGene Technologies Inc. PerkinElmer Inc. RayBiotech Inc. Roche Diagnostics Sengenics Corporation Pte Ltd. Shimadzu Corporation Sigma-Aldrich Corporation Thermo Fisher Scientific Inc. This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include: Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs. Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015. Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends. Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape. Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players. Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities. Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage. Key Attributes Report Attribute Details No. of Pages 216 Forecast Period 2024-2030 Estimated Market Value (USD) in 2024 $2.4 Billion Forecasted Market Value (USD) by 2030 $3.4 Billion Compound Annual Growth Rate 6% Regions Covered Global MARKET OVERVIEW Influencer Market Insights World Market Trajectories Tariff Impact on Global Supply Chain Patterns Protein Chips - Global Key Competitors Percentage Market Share in 2025 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E) MARKET TRENDS & DRIVERS Increasing Focus on Personalized Medicine Propels Demand for High-Throughput Protein Analysis Growth in Biomarker Discovery and Disease Profiling Expands Applications in Oncology and Neurology Rising Adoption of Multiplexed Assays Accelerates Use in Drug Development Pipelines Integration of AI and Machine Learning Enhances Data Interpretation and Diagnostic Accuracy Expansion of Proteomics Research in Academic Institutions Drives Product Demand Technological Advancements in Microarray Surface Chemistry Strengthen Analytical Performance Growing Prevalence of Chronic Diseases Spurs Use of Protein Chips in Clinical Diagnostics Miniaturization and Automation of Laboratory Processes Propel Adoption in Research Settings Government Funding for Life Sciences R&D Supports Market Growth Across Developed Nations Partnerships Between Biotech Firms and CROs Increase Commercialization of Custom Protein Arrays Increased Interest in Immune Profiling and Vaccine Development Boosts Segment Demand Shift Toward Point-of-Care Diagnostics Expands Use of Lab-on-a-Chip Solutions Rising Throughput Requirements in Genomic-Proteomic Integration Strengthens Market Appeal Emergence of Next-Gen Antibody-Based Chips Drives Innovation and Competitive Differentiation Regulatory Advancements and Approval Pathways Facilitate Clinical Use of Protein Microarrays For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Protein Chips Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
